SEC Form 4 · accession 0001461755-16-000159
Atlantic Capital Bancshares, Inc. · ACBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walter M Deriso Jr.
Director
Period of report
Nov 25, 2016
Accepted (ET)
Nov 29, 2016 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461755
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2016 | M | 2,800 | $10.00 | A | 173,249 | D | |
| Common StockF2 | Nov 25, 2016 | S | 2,800 | $16.3536 | D | 170,449 | D | |
| Common Stock | Nov 28, 2016 | M | 7,200 | $10.00 | A | 177,649 | D | |
| Common StockF3 | Nov 28, 2016 | S | 7,200 | $16.1948 | D | 170,449 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $10.00 | Nov 25, 2016 | M | 2,800 | D | May 14, 2007 | May 14, 2017 | Common Stock | 2,800 | 10,190 | D |
| Stock Option (Right to Buy)F4 | $10.00 | Nov 28, 2016 | M | 7,200 | D | May 14, 2007 | May 14, 2017 | Common Stock | 7,200 | 2,990 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2015.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $16.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The option became fully vested three years after the date of grant listed.